PortfoliosLab logoPortfoliosLab logo
STRL vs. VRNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

STRL vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sterling Infrastructure, Inc. (STRL) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


STRL

1D
-7.86%
1M
-23.79%
6M
88.09%
YTD
115.83%
1Y
161.57%
3Y*
124.83%
5Y*
99.02%
10Y*
60.71%
ALL TIME*
20.40%

VRNA

1D
1M
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$420.88M$635.51M$597.48M

STRL vs. VRNA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
STRL
Sterling Infrastructure, Inc.
115.83%81.79%91.57%168.08%24.71%41.32%32.17%29.29%-33.11%71.37%
VRNA
Verona Pharma plc
0.00%130.21%133.60%-23.92%288.84%-4.00%21.74%-40.41%-18.71%-12.07%

Correlation

The correlation between STRL and VRNA is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Apr 27, 2017

0.12

The correlation between STRL and VRNA shifts across timeframes, from -0.04 (1 year) to 0.18 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

STRL:

$20.28B

VRNA:

$9.72B

EPS

STRL:

$11.16

VRNA:

-$0.69

PS Ratio

STRL:

7.11

VRNA:

57.97

PB Ratio

STRL:

17.25

VRNA:

34.92

Total Revenue (TTM)

STRL:

$2.88B

VRNA:

$167.65M

Gross Profit (TTM)

STRL:

$664.66M

VRNA:

$159.52M

EBITDA (TTM)

STRL:

$429.99M

VRNA:

-$40.86M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

STRL vs. VRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

STRL
STRL Risk / Return Rank: 9191
Overall Rank
STRL Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
STRL Sortino Ratio Rank: 9090
Sortino Ratio Rank
STRL Omega Ratio Rank: 8989
Omega Ratio Rank
STRL Calmar Ratio Rank: 9494
Calmar Ratio Rank
STRL Martin Ratio Rank: 9393
Martin Ratio Rank

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

STRL vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sterling Infrastructure, Inc. (STRL) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


STRLVRNADifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.35

Calmar ratioReturn relative to maximum drawdown

4.55

Martin ratioReturn relative to average drawdown

11.43

STRL vs. VRNA - Sharpe Ratio Comparison


Loading charts...

Drawdowns

STRL vs. VRNA - Drawdown Comparison


Loading charts...

Drawdown Indicators


STRLVRNADifference

Max Drawdown

Largest peak-to-trough decline

-92.51%

Max Drawdown (1Y)

Largest decline over 1 year

-35.74%

Max Drawdown (3Y)

Largest decline over 3 years

-47.67%

Max Drawdown (5Y)

Largest decline over 5 years

-47.67%

Max Drawdown (10Y)

Largest decline over 10 years

-59.60%

Current Drawdown

Current decline from peak

-33.49%

Average Drawdown

Average peak-to-trough decline

-46.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.20%

Volatility

STRL vs. VRNA - Volatility Comparison


Loading charts...

Volatility by Period


STRLVRNADifference

Volatility (1M)

Calculated over the trailing 1-month period

22.92%

Volatility (6M)

Calculated over the trailing 6-month period

67.34%

Volatility (1Y)

Calculated over the trailing 1-year period

85.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

57.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

54.08%

Dividends

STRL vs. VRNA - Dividend Comparison

Neither STRL nor VRNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

STRL vs. VRNA - Financials Comparison

This section allows you to compare key financial metrics between Sterling Infrastructure, Inc. and Verona Pharma plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
825.68M
75.14M
(STRL) Total Revenue
(VRNA) Total Revenue
Values in USD except per share items

STRL vs. VRNA - Profitability Comparison

The chart below illustrates the profitability comparison between Sterling Infrastructure, Inc. and Verona Pharma plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
23.5%
95.4%
Portfolio components
STRL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Sterling Infrastructure, Inc. reported a gross profit of 194.30M and revenue of 825.68M. Therefore, the gross margin over that period was 23.5%.

VRNA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Verona Pharma plc reported a gross profit of 71.68M and revenue of 75.14M. Therefore, the gross margin over that period was 95.4%.

STRL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Sterling Infrastructure, Inc. reported an operating income of 2.36M and revenue of 825.68M, resulting in an operating margin of 0.3%.

VRNA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Verona Pharma plc reported an operating income of 9.69M and revenue of 75.14M, resulting in an operating margin of 12.9%.

STRL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Sterling Infrastructure, Inc. reported a net income of 95.97M and revenue of 825.68M, resulting in a net margin of 11.6%.

VRNA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Verona Pharma plc reported a net income of 8.69M and revenue of 75.14M, resulting in a net margin of 11.6%.


Frequently Asked Questions


STRL and VRNA have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for STRL and VRNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer